z-logo
open-access-imgOpen Access
Retreatment with rituximab offers a similar survival benefit as maintenance therapy in patients with low tumor burden follicular lymphoma
Author(s) -
Barton Mary Kay
Publication year - 2014
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21255
Subject(s) - rituximab , follicular lymphoma , medicine , maintenance therapy , lymphoma , oncology , follicular phase , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here